Mechanisms of Motivational Interviewing for Antiretroviral Medication Adherence in People with HIV

Hogan, Ailbhe; Catley, Delwyn; Goggin, Kathy; Evangeli, Michael

doi:10.1007/s10461-020-02846-w

Cited by 5 publications

(3 citation statements)

References 49 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This aligns with the theoretical framework of offering youth friendly services, motivational interviewing, and cognitive behavioural therapy to change behaviour. 26,27,28 These findings are consistent with the Thai study that showed the potential of an empowerment programme for youth in improving adherence to ART. 17 The study results showed that young people who never attended the EACGI showed the lowest rates of suppression on the switched regimen.…”

Section: Discussionsupporting

confidence: 87%

Group counselling for adherence support among young people failing first-line antiretroviral therapy in Zimbabwe

Kasimonje¹,

Shamu

Mudzviti

et al. 2021

Southern African Journal of HIV Medicine

View full text Add to dashboard Cite

Section: Discussionsupporting

confidence: 87%

Group counselling for adherence support among young people failing first-line antiretroviral therapy in Zimbabwe

Kasimonje¹,

Shamu

Mudzviti

et al. 2021

Southern African Journal of HIV Medicine

View full text Add to dashboard Cite

“…Having these positive outcome expectations is a key factor for promoting health behaviours according to social cognitive theory 31 . The use of motivational interviewing can help identify and improve outcome expectations 32‐35 . This idea is further supported by our finding that many Veterans reported being motivated by provider education about the importance of taking medications and the harmful effects of HCV.…”

Section: Discussionmentioning

confidence: 56%

Patient perceptions of successful hepatitis C virus treatment adherence in Veterans

et al. 2021

View full text Add to dashboard Cite

Background: Treatment adherence remains a potential barrier to achieving population-level hepatitis C virus (HCV) elimination by 2030. We aimed to understand barriers to and facilitators of HCV treatment adherence pre-and post-directacting antiviral (DAA) treatment.Methods: A cohort of US Veterans who were initiating DAA treatment completed pre-and post-treatment surveys assessing demographic information, psychological symptoms and perceived barriers to adherence. DAA adherence was assessed through self-report and pharmacy records. Sustained virologic response (SVR) was evaluated using the medical record. Mann-Whitney U, Fisher's exact tests, and logistic regression were employed to evaluate associations of patient characteristics and survey responses with adherence and SVR.Results: Of 97 participants, the majority were male (98%), white (62%), low-income (less than 35 000/y; 82%), and had a history of self-reported prior substance use (93%). The most common anticipated adherence barrier prior to treatment was having side effects (21%). Over follow-up, 62% of participants missed doses and 84% achieved SVR. Decreased pain (OR 0.32, 95% CI 1.06-1.72), agreeing with 'the medication will improve my health' (OR 4, 95% CI 1.22-15.8) and disagreeing with being 'worried about my liver disease getting worse' (OR 0.2, 95% CI 0.05, 0.59) predicted successfully achieving SVR. After treatment, the most commonly reported barriers to adherence were being busy (13%) and being away from home (13%). Veterans reported non-significantly decreased substance use after treatment (38% vs 28%, P = .18). Conclusion:In this population of Veterans with high rates of substance use, most participants missed doses but still achieved SVR. HCV treatment may also serve as an opportunity for substance use treatment.

show abstract

“…Some studies have failed to show an impact on ART adherence from MI. More research is warranted to investigate non-motivational challenges as adherence is determined by both motivational and non-motivational factors [8]. However, even with some mixed results on efficaciousness, the overall literature indicates MI can have an important impact on behavior change.…”

Section: Introductionmentioning

confidence: 99%

Provider perspectives on the use of motivational interviewing and problem-solving counseling paired with the point-of-care nucleic acid test for HIV care

et al. 2022

View full text Add to dashboard Cite

Aims To evaluate provider perspectives on the use of a point-of-care nucleic acid test (POC NAT) and preferential opinions for motivational interviewing (MI) or problem-solving counseling (PSC) as an ultra-brief intervention for patients experiencing challenges to antiretroviral therapy (ART) adherence. Methods A qualitative study was conducted among providers at an HIV care clinic in Seattle, Washington. Ten in-depth interviews with HIV care providers were completed, which explored determinants of acceptability, feasibility and preferences for a combined adherence counseling and POC NAT intervention for patients living with HIV. Interviews were analyzed through consensus coding and the Five A’s Framework to inform thematic analysis. Results Providers favored the use of a combined adherence counseling technique and POC NAT for their non-adherent patients living with HIV. Providers believed the intervention was an improvement on current assessment and advising practices. However, concerns about extended wait times for the POC NAT results influenced perceptions about feasibility around clinic flow and incorporation into clinic practice. Providers believed that acceptability of POC NAT implementation would be enhanced by including a subset of patient populations whom tend to be in the clinic for longer periods, and in tandem face greater ART adherence challenges. Conclusion The GAIN Study will be the first project to evaluate the implementation of POC NAT in the U.S. Continued formative work is ongoing and may illustrate how best to address feasibility and concern around the two-hour time to result. The planned GAIN study will incorporate some of the findings found in this qualitative study and pilot this intervention, including a time-in-motion analyses of clinic flow, which may help reduce perceived wide-scale adaptation of POC NAT and ART adherence counselling among PLHW. Future work, including a shorter time to results and/or lower limit detection could make a significant improvement in the provision of HIV care.

show abstract

Mechanisms of Motivational Interviewing for Antiretroviral Medication Adherence in People with HIV

Cited by 5 publications

References 49 publications

Group counselling for adherence support among young people failing first-line antiretroviral therapy in Zimbabwe

Group counselling for adherence support among young people failing first-line antiretroviral therapy in Zimbabwe

Patient perceptions of successful hepatitis C virus treatment adherence in Veterans

Provider perspectives on the use of motivational interviewing and problem-solving counseling paired with the point-of-care nucleic acid test for HIV care

Contact Info

Product

Resources

About